Next-Gen Preclinical Validation

Decoding Failure Mechanisms in Implantable Neurotechnology

ACCREVIA de-risks neural interfaces through integrated biological, engineering, and computational characterization—accelerating your path to clinical translation.

Expertise & Services

Mechanistic Characterization Capabilities

01

In Vivo Electrophysiology

Continuous signal stability analysis, single-unit isolation, signal-to-noise optimization, and longitudinal neural dynamics.

02

Quantitative Histopathology

High-resolution tissue-interface evaluation, glial scar morphometry, neuroinflammatory profiling, and neuronal density mapping.

03

Device Failure Diagnostics

Impedance spectroscopy, material degradation analysis, benchtop mechanical testing, and bio-encapsulation assessment.

04

Computational Intelligence

Machine learning-driven signal extraction, predictive computational modeling, and automated histology image segmentation.

Target Platforms

Supported Neurotechnologies

Brain–Computer Interfaces (BCIs)
Deep Brain Stimulation (DBS)
Peripheral Nerve Interfaces
Bioelectronic Therapeutics
Neural Prosthetics
Closed-Loop Neuromodulation

De-Risk Your Neural Interface Development

Connect with our scientific directors to discuss custom preclinical study designs and validation strategies.